Primary Care and Population Health
Showing 11-20 of 26 Results
-
Bryant Lin
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests-Digital Health
-Medical device design, prototyping, testing and clinical trials
-Behavioral determinants of chronic disease
-Novel diagnostic processes for medical mysteries
-Asian Health
-Medical Humanities and Arts
-Medical Technology -
Steven Lin
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsArtificial intelligence and machine learning in healthcare
Primary care and population health
Value added medical education -
Brian Linde, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Linde is a double board-certified, fellowship-trained internal medicine doctor with the Department of Medicine, Division of Primary Care & Population Health at Stanford University School of Medicine. He is board certified in both internal medicine and occupational and environmental medicine. He is fellowship trained in occupational and environmental medicine.
Dr. Linde specializes in preventing, managing, and treating work-related injuries and diseases. He uses his expertise to improve the physical and mental wellness of his patients while reducing their exposure to occupational and environmental hazards. As a public health expert, Dr. Linde also focuses on enhancing the health of entire populations through strategies and policies that benefit communities as a whole.
His academic interests include inhalational exposures and occupational lung diseases. During the COVID-19 pandemic, Dr. Linde studied how to increase adherence to infection prevention recommendations in clinical settings. He has also worked on guidance related to exposure to per- and polyfluoroalkyl substances (PFAS). These chemicals, which are found in water, food, and fabrics, are an ongoing public health concern. Dr. Linde has also researched how to improve the mental and physical health of medical students and ways to prevent physician burnout.
Dr. Linde has published in many peer-reviewed journals, including Current Opinion in Pulmonary Medicine and Academic Medicine. As a member of the Committee on the Guidance on PFAS Testing and Health Outcomes, Dr. Linde contributed to Guidance on PFAS Exposure, Testing, and Clinical Follow-Up, a publication of the National Academies of Sciences, Engineering, and Medicine. He was also a reviewer for Archives of Environmental & Occupational Health and the American Journal of Industrial Medicine.
He has written book chapters for Modern Occupational Diseases: Diagnosis, Epidemiology, Management and Prevention and Patty’s Industrial Hygiene. He wrote about preventing occupational and environmental pulmonary disorders for the Merck Manuals Professional Edition. Dr. Linde has been invited to speak at workshops and presentations all over the nation about a range of topics, including environmental health risks in underserved communities and the health effects of floods.
Dr. Linde is a member of the American Board of Internal Medicine and the American Board of Preventive Medicine. He is also a member of the American College of Physicians and the American College of Occupational and Environmental Medicine. -
Christine Kee Liu
Associate Professor of Medicine (Primary Care and Population Health)
BioDr. Liu and her research program are dedicated to improving the lives of older adults with kidney disease. Currently her research focuses on mobility, which is the ability to move safely and reliably from one place to another. In older adults, poor mobility strongly predicts future disability and death. Retaining mobility has been cited by older adults as fundamental to quality to life; yet many older persons with kidney disease, especially those with late stage chronic kidney disease or outright kidney failure, have trouble just walking across the room or transferring to a chair. Dually trained in geriatric medicine and epidemiology, Dr. Liu also has significant expertise in older adult clinical trials, including safety trials of novel agents as well as intervention studies to reduce infections in older populations.
